Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients ; volume:15 ; number:1 ; day:19 ; month:10 ; year:2015 ; pages:1-9 ; date:12.2015
BMC cancer ; 15, Heft 1 (19.10.2015), 1-9, 12.2015
- Creator
-
Horikawa, Naoki
- Contributor
-
Baba, Tsukasa
Matsumura, Noriomi
Murakami, Ryusuke
Abiko, Kaoru
Hamanishi, Junzo
Yamaguchi, Ken
Koshiyama, Masafumi
Yoshioka, Yumiko
Konishi, Ikuo
SpringerLink (Online service)
- DOI
-
10.1186/s12885-015-1703-1
- URN
-
urn:nbn:de:1111-2016110618076
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Horikawa, Naoki
- Baba, Tsukasa
- Matsumura, Noriomi
- Murakami, Ryusuke
- Abiko, Kaoru
- Hamanishi, Junzo
- Yamaguchi, Ken
- Koshiyama, Masafumi
- Yoshioka, Yumiko
- Konishi, Ikuo
- SpringerLink (Online service)
Other Objects (12)
Evaluation of pathological response to neoadjuvant chemotherapy in locally advanced cervical cancer
CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy
Variation of PD-L1 expression in locally advanced cervical cancer following neoadjuvant chemotherapy
Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer
The E2F4 prognostic signature predicts pathological response to neoadjuvant chemotherapy in breast cancer patients
Tumor-infiltrating CD8+ and FOXP3+ lymphocytes before and after neoadjuvant chemotherapy in cervical cancer
Serum nucleosomes during neoadjuvant chemotherapy in patients with cervical cancer. Predictive and prognostic significance
Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy
Multimodal MRI-based deep-radiomics model predicts response in cervical cancer treated with neoadjuvant chemoradiotherapy
Chemotherapy for Cervical Cancer
Chemotherapy for Cervical Cancer
Preoperative (neoadjuvant) chemotherapy : with 49 tables
Evaluation of pathological response to neoadjuvant chemotherapy in locally advanced cervical cancer
CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy
Variation of PD-L1 expression in locally advanced cervical cancer following neoadjuvant chemotherapy
Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer
The E2F4 prognostic signature predicts pathological response to neoadjuvant chemotherapy in breast cancer patients
Tumor-infiltrating CD8+ and FOXP3+ lymphocytes before and after neoadjuvant chemotherapy in cervical cancer
Serum nucleosomes during neoadjuvant chemotherapy in patients with cervical cancer. Predictive and prognostic significance
Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy
Multimodal MRI-based deep-radiomics model predicts response in cervical cancer treated with neoadjuvant chemoradiotherapy
Chemotherapy for Cervical Cancer
Chemotherapy for Cervical Cancer
Preoperative (neoadjuvant) chemotherapy : with 49 tables
Evaluation of pathological response to neoadjuvant chemotherapy in locally advanced cervical cancer
CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy
Variation of PD-L1 expression in locally advanced cervical cancer following neoadjuvant chemotherapy
Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer
The E2F4 prognostic signature predicts pathological response to neoadjuvant chemotherapy in breast cancer patients
Tumor-infiltrating CD8+ and FOXP3+ lymphocytes before and after neoadjuvant chemotherapy in cervical cancer
Serum nucleosomes during neoadjuvant chemotherapy in patients with cervical cancer. Predictive and prognostic significance
Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy
Multimodal MRI-based deep-radiomics model predicts response in cervical cancer treated with neoadjuvant chemoradiotherapy
Chemotherapy for Cervical Cancer
Chemotherapy for Cervical Cancer